Home Health Care News July 24, 2024
Amedisys Inc. (Nasdaq: AMED) is waiting for multiple big-time transactions to come to fruition by year end. In the meantime, it continues to grow its non-Medicare revenue and its high-acuity care business considerably.
The company released its second-quarter earnings on Wednesday, without an accompanying call. It has not held an official earnings call since UnitedHealth Group (NYSE: UNH) agreed to acquire it in June of 2023, which is customary.
Home health revenue checked in at $377.4 million in the second quarter, reflecting a nearly 8% year-over-year increase. Hospice revenue checked in at $204 million, reflecting an over 2% year-over-year increase.
Amedisys’ non-Medicare home health revenue grew significantly once again, to $161.3 million in the quarter. That represents a 24% year-over-year...
Today's Sponsors
Today's Sponsor